Literature DB >> 11209956

Expression of the high-affinity glutamate transporter EAAT4 in mammalian cerebral cortex.

A Massie1, F Vandesande, L Arckens.   

Abstract

RT-PCR, immunocytochemistry and Western blotting were used to study the expression of the glutamate transporter EAAT4 in the cerebral cortex of cat and mouse. By means of RT-PCR we were able to detect EAAT4 mRNA in the cerebral cortex of both species. Sequencing ensured the specificity of the amplified fragment. Immunocytochemistry and Western blotting enabled us to localize EAAT4 protein in cat and mouse cerebral cortex. Intense EAAT4 immunoreactivity was found in the soma and dendrites of neurons mainly of layers II, III and V. For both species, the signal in the cerebellum was very intense and confined to the molecular and Purkinje cell layer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11209956     DOI: 10.1097/00001756-200102120-00041

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  9 in total

1.  Probing for improved potency and in vivo bioavailability of excitatory amino acid transporter subtype 1 inhibitors UCPH-101 and UCPH-102: design, synthesis and pharmacological evaluation of substituted 7-biphenyl analogs.

Authors:  Mette N Erichsen; Jeanette Hansen; Josep A Ruiz; Charles S Demmer; Bjarke Abrahamsen; Jesper F Bastlund; Christoffer Bundgaard; Anders A Jensen; Lennart Bunch
Journal:  Neurochem Res       Date:  2014-02-28       Impact factor: 3.996

Review 2.  The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies.

Authors:  Wei Hu; Matthew L MacDonald; Daniel E Elswick; Robert A Sweet
Journal:  Ann N Y Acad Sci       Date:  2014-10-14       Impact factor: 5.691

Review 3.  Astroglial glutamate transporters coordinate excitatory signaling and brain energetics.

Authors:  Michael B Robinson; Joshua G Jackson
Journal:  Neurochem Int       Date:  2016-03-21       Impact factor: 3.921

4.  RETRACTED: Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients.

Authors:  Jagadeesh Sridhara Rao; Matthew Kellom; Edmund Arthur Reese; Stanley Isaac Rapoport; Hyung-Wook Kim
Journal:  J Affect Disord       Date:  2011-09-16       Impact factor: 4.839

5.  Disturbed neurotransmitter transporter expression in Alzheimer's disease brain.

Authors:  Kevin H Chen; Edmund A Reese; Hyung-Wook Kim; Stanley I Rapoport; Jagadeesh S Rao
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 6.  Transporters for L-glutamate: an update on their molecular pharmacology and pathological involvement.

Authors:  P M Beart; R D O'Shea
Journal:  Br J Pharmacol       Date:  2006-11-06       Impact factor: 8.739

Review 7.  Glutamate transporters in the biology of malignant gliomas.

Authors:  Stephanie M Robert; Harald Sontheimer
Journal:  Cell Mol Life Sci       Date:  2013-11-27       Impact factor: 9.261

8.  Structure-activity-relationship study of N-acyl-N-phenylpiperazines as potential inhibitors of the Excitatory Amino Acid Transporters (EAATs): improving the potency of a micromolar screening Hit is not truism.

Authors:  Tri Hv Huynh; Charles S Demmer; Bjarke Abrahamsen; Emil Marcher; Mikael Frykman; Anders A Jensen; Lennart Bunch
Journal:  Springerplus       Date:  2013-03-14

Review 9.  Homeostasis of the Intraparenchymal-Blood Glutamate Concentration Gradient: Maintenance, Imbalance, and Regulation.

Authors:  Wei Bai; Yuan-Guo Zhou
Journal:  Front Mol Neurosci       Date:  2017-12-05       Impact factor: 5.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.